Gurpreet Ratra

Gurpreet Ratra is the Chief Business Officer at Kate Therapeutics, a company developing genetic medicines for muscle diseases. Prior to this, Gurpreet held the same role at Skyline Therapeutics and has a background in business development in the biotechnology industry. Gurpreet also has experience in biopharmaceutical market research, strategy, and consulting across various therapeutic areas. Education wise, Gurpreet holds an MBA in Finance from the University of California, Berkeley, among other degrees in toxicology and pharmacology.